The Carlyle Group Inc.

Last updated September 27, 2026

Organization details

Legal name
The Carlyle Group Inc.
Ownership
Public
Status
Active
SIC code
6282 — Investment Advice
Jurisdiction of incorporation
Delaware
Headquarters city
Washington
Headquarters state / province
District of Columbia
Headquarters country
United States
Fiscal year end
December
Ticker symbol
CG
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001527166
EIN
45-2832612

Board of directors

Chief executives

Harvey M. Schwartz · Chief Executive Officer
Dates unknown

Director election results

Annual meeting of June 3, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

11 of this board's directors also sit on 17 other boards.

Network of The Carlyle Group Inc.'s board connections Acuity Inc. Acuity Inc. Bristol-Myers Squibb Company Bristol-Myers Squibb C... Ciena Corporation Ciena Corporation Danaher Corporation Danaher Corporation Diamondrock Hospitality Company Diamondrock Hospitalit... Gilead Sciences Inc. Gilead Sciences Inc. Loews Corporation Loews Corporation Marriott Vacations Worldwide Corporation Marriott Vacations Wor... Moderna Inc. Moderna Inc. Pediatrix Medical Group Inc. Pediatrix Medical Grou... SoFi Technologies Inc. SoFi Technologies Inc. StandardAero Inc. StandardAero Inc. Target Corporation Target Corporation The Progressive Corporation The Progressive Corpor... The Walt Disney Company The Walt Disney Compan... Veralto Corp Veralto Corp Anthony Welters Anthony Welters David M. Rubenstein David M. Rubenstein Derica W. Rice Derica W. Rice Harvey M. Schwartz Harvey M. Schwartz James H. Hance Jr. James H. Hance Jr. Lawton W. Fitt Lawton W. Fitt Linda Filler Linda Filler Mark S. Ordan Mark S. Ordan Peter J. Clare Peter J. Clare William Joseph Shaw William Joseph Shaw The Carlyle Group Inc.
Shared director Other board Same sector +1 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$75,779,750
3 sales by 1 insider
Date Insider Transaction Shares Price Value
Sep 11, 2026 David M. Rubenstein Director Gift −100,000 — —
Sep 11, 2026 David M. Rubenstein Director Open-market sale −400,000 $42.74 $17,096,000
Aug 26, 2026 Andrews Charles Elliott Jr. Officer (Chief Accounting Officer) Grant or award +304 — —
Aug 26, 2026 Harvey M. Schwartz Director, Officer (Chief Executive Officer) Grant or award +19,240 — —
Aug 26, 2026 Redett John C. Officer (Co-President) Grant or award +8,302 — —
Aug 26, 2026 Justin Plouffe Officer (Chief Financial Officer) Grant or award +3,769 — —
Aug 26, 2026 Mark David Jenkins Officer (Co-President) Grant or award +6,264 — —
Aug 26, 2026 Jeffrey Nedelman Officer (Co-President) Grant or award +6,615 — —
Aug 26, 2026 LoBue Lindsay Officer (Chief Operating Officer) Grant or award +2,657 — —
Aug 26, 2026 Heinzelman Kate Elizabeth Officer (General Counsel) Grant or award +78 — —
Aug 1, 2026 Andrews Charles Elliott Jr. Officer (Chief Accounting Officer) Shares withheld for tax −12,364 $46.02 $568,991
Aug 1, 2026 Redett John C. Officer (Co-President) Shares withheld for tax −124,558 $46.02 $5,732,159
Aug 1, 2026 Justin Plouffe Officer (Chief Financial Officer) Shares withheld for tax −62,533 $46.02 $2,877,769
Aug 1, 2026 Mark David Jenkins Officer (Co-President) Shares withheld for tax −124,793 $46.02 $5,742,974
Aug 1, 2026 Jeffrey Nedelman Officer (Co-President) Shares withheld for tax −43,081 $46.02 $1,982,588

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.